What if we could prevent tumor formation? Detect cancer without invasive biopsies? Or cure even the most aggressive cancers? For those willing to ask the big questions in cancer research, Applied Biosystems solutions are where the answers come together. We deliver the accuracy, speed, and breadth of solutions you need to facilitate your oncology research from discovery through delivery of life-changing treatments.
Advances in genetic analysis technologies—qPCR, digital PCR (dPCR), Sanger sequencing, and NGS—have enabled researchers and clinicians to pinpoint alterations in some patients' tumors and to deploy more targeted treatments for non-small-cell lung cancer (NSCLC), extending survival rates significantly.
In this on-demand webinar, Professor Michael Thomas, head of the department of thoracic oncology at the Thoraxklinik University of Heidelberg, discusses how synergistic advancements in molecular capabilities, targeted therapy, and immune checkpoint inhibition (ICI) development offer a bright future for lung cancer treatment.
Applied Biosystems solutions include a comprehensive range of tools that are extensively utilized in cancer research. In this eBook, learn how genomics can be incorporated into cancer research, from decoding cancer signatures from extracellular vesicles to using circulating tumor DNA to predict survival rates.
New advances in gold-standard genetic technologies such as qPCR, CE sequencing, and microarrays continue to drive fundamental and applied discoveries in oncology. More recent technologies such as NGS, microfluidic dPCR, and others are enabling researchers to pursue new territory with greater sensitivity, precision, and speed. This eBook explores how genetic technologies have enabled some of the most recent and exciting discoveries in several areas of cancer research.
For Research Use Only. Not for use in diagnostic procedures.